Xeomin 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9DH2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,721
Award facts
- Contract value 100% obligated
- $14,720.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,720.50 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 unit vials, with an ultimate completion date of December 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. The award represents a child delivery order issued under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs.
This procurement supplies Xeomin (incobotulinumtoxinA), a neurotoxin medication commonly used for treating muscle spasticity, dystonia, and other neurological conditions within military and federal healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supplying specialized pharmaceutical products, branded and generic medications, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders underscores its capability to meet federal procurement requirements and maintain reliable supply chains for essential medical commodities.
Quick answers
Who was awarded contract SPE2DR26F9DH2?
SPE2DR26F9DH2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F9DH2 worth?
The government has obligated $14,721 on SPE2DR26F9DH2.
Is contract SPE2DR26F9DH2 an order under another contract?
Yes. SPE2DR26F9DH2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DH2 competed?
The extent of competition for SPE2DR26F9DH2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award